PharmiWeb.com - Global Pharma News & Resources

Biotech - Press Releases

Date Title Company
27-Aug-2021 CD Formulation Announces Ability to Develop Liquid Dosage Forms CD Formulation
26-Aug-2021 Moderna Completes Submission of Biologics License Application to the U.S. Food and Drug Administration for its COVID-19 Vaccine Moderna
25-Aug-2021 Almac Group and PILA PHARMA Ink Manufacturing Agreement Almac
25-Aug-2021 Moderna to Host Virtual R&D Day on Thursday, September 9, 2021 Moderna
24-Aug-2021 Yposkesi joins BioPhorum – global cell and gene therapy consortium Andrew Lloyd Associates
24-Aug-2021 PTC Therapeutics Announces Waylivra™ Approval in Brazil as First Treatment for Familial Chylomicronemia Syndrome PTC Therapeutics
23-Aug-2021 Targeting the Putamen with Gene Therapy Leads to Sustained Improvements in Motor and Non-Motor Functions in Children with AADC Deficiency PTC Therapeutics, Inc.
22-Aug-2021 Anatara’s IBS-D clinical trial to leverage Microba Life Sciences’ precision microbiome analysis Microba Life Sciences
20-Aug-2021 Almac Group and PILA PHARMA Ink Manufacturing Agreement Almac
20-Aug-2021 Human Bone Marrow-derived Mononuclear Cells and Their Applications AcceGen
19-Aug-2021 Antimicrobial Susceptibility Testing Market Growth And Business Intelligence MarketsandMarkets
17-Aug-2021 Cidara Therapeutics and Mundipharma Announce Completion of Enrollment in the Phase 3 ReSTORE Trial of Rezafungin for the Treatment of Candidemia and Invasive Candidiasis Mundipharma
17-Aug-2021 Novavax Appoints Biopharmaceutical Veterans Jim Kelly as Chief Financial Officer and Nasir Egal, Ph.D., as Senior Vice President of Quality Assurance Novavax
17-Aug-2021 Moderna Announces Supply Agreement with Canada for Expanded Supply of Moderna’s COVID-19 Vaccine in 2022, in 2023 and in 2024 Moderna
12-Aug-2021 Biotium launches optimized solution for exosome detection by flow cytometry Biotium
12-Aug-2021 PureTech Announces that Imbrium Therapeutics Has Exercised License Option to LYT-503/IMB-150 for Interstitial Cystitis/Bladder Pain Syndrome PureTech Health plc
11-Aug-2021 PONVORY®▼ (ponesimod), a Once Daily, Oral Therapy Authorised in Great Britain for the Treatment of Adults with Relapsing Forms of Multiple Sclerosis (RMS) with Active Disease Defined by Clinical or Imaging Features Janssen
11-Aug-2021 Biotech Start-up Takes Another Stride Toward Flu Cure COVIMRO Ltd
10-Aug-2021 ArisGlobal Awarded Frost & Sullivan 2021 North America Customer Value Leadership ArisGlobal
10-Aug-2021 CytoSMART introduces new, label-free live-cell microscopy solutions with high image quality CytoSMART